March 2, 2020 / 8:33 PM / a month ago

BRIEF-Sanofi Says U.S. List Price For Sarclisa Is $650 Per 100 Mg Vial & $3,250 Per 500 Mg Vial

March 2 (Reuters) - Sanofi SA:

* SANOFI : FDA APPROVES SARCLISA® (ISATUXIMAB-IRFC) FOR PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA

* SANOFI - U.S. LIST PRICE (WHOLESALE ACQUISITION COST, OR WAC) FOR SARCLISA IS $650 PER 100 MG VIAL & $3,250 PER 500 MG VIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below